» Articles » PMID: 25089863

Subclinical Thyroid Dysfunction and the Risk for Fractures: a Systematic Review and Meta-analysis

Overview
Journal Ann Intern Med
Specialty General Medicine
Date 2014 Aug 5
PMID 25089863
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Data on the association between subclinical thyroid dysfunction and fractures conflict.

Purpose: To assess the risk for hip and nonspine fractures associated with subclinical thyroid dysfunction among prospective cohorts.

Data Sources: Search of MEDLINE and EMBASE (1946 to 16 March 2014) and reference lists of retrieved articles without language restriction.

Study Selection: Two physicians screened and identified prospective cohorts that measured thyroid function and followed participants to assess fracture outcomes.

Data Extraction: One reviewer extracted data using a standardized protocol, and another verified data. Both reviewers independently assessed methodological quality of the studies.

Data Synthesis: The 7 population-based cohorts of heterogeneous quality included 50,245 participants with 1966 hip and 3281 nonspine fractures. In random-effects models that included the 5 higher-quality studies, the pooled adjusted hazard ratios (HRs) of participants with subclinical hyperthyroidism versus euthyrodism were 1.38 (95% CI, 0.92 to 2.07) for hip fractures and 1.20 (CI, 0.83 to 1.72) for nonspine fractures without statistical heterogeneity (P = 0.82 and 0.52, respectively; I2= 0%). Pooled estimates for the 7 cohorts were 1.26 (CI, 0.96 to 1.65) for hip fractures and 1.16 (CI, 0.95 to 1.42) for nonspine fractures. When thyroxine recipients were excluded, the HRs for participants with subclinical hyperthyroidism were 2.16 (CI, 0.87 to 5.37) for hip fractures and 1.43 (CI, 0.73 to 2.78) for nonspine fractures. For participants with subclinical hypothyroidism, HRs from higher-quality studies were 1.12 (CI, 0.83 to 1.51) for hip fractures and 1.04 (CI, 0.76 to 1.42) for nonspine fractures (P for heterogeneity = 0.69 and 0.88, respectively; I2 = 0%).

Limitations: Selective reporting cannot be excluded. Adjustment for potential common confounders varied and was not adequately done across all studies.

Conclusion: Subclinical hyperthyroidism might be associated with an increased risk for hip and nonspine fractures, but additional large, high-quality studies are needed.

Primary Funding Source: Swiss National Science Foundation.

Citing Articles

The preferred surgical choice for intermediate-risk papillary thyroid cancer: total thyroidectomy or lobectomy? A systematic review and meta-analysis.

Cao M, Yu T, Miao X, Wu Z, Wang W Int J Surg. 2024; 110(8):5087-5100.

PMID: 38967517 PMC: 11325972. DOI: 10.1097/JS9.0000000000001556.


The relationship of hip fracture and thyroid disorders: a systematic review.

SeyedAlinaghi S, Yarmohammadi S, Dashti M, Ghasemzadeh A, Siami H, Molla A Front Endocrinol (Lausanne). 2023; 14:1230932.

PMID: 37881501 PMC: 10597696. DOI: 10.3389/fendo.2023.1230932.


Evaluation and Management of Bone Health in Patients with Thyroid Diseases: A Position Statement of the Korean Thyroid Association.

Hong A, Kang H Endocrinol Metab (Seoul). 2023; 38(2):175-189.

PMID: 37150514 PMC: 10164499. DOI: 10.3803/EnM.2023.1701.


The impact of the management strategies for patients with subclinical hypothyroidism on long-term clinical outcomes: An umbrella review.

Bauer B, Azcoaga-Lorenzo A, Agrawal U, Fagbamigbe A, McCowan C PLoS One. 2022; 17(5):e0268070.

PMID: 35587500 PMC: 9119548. DOI: 10.1371/journal.pone.0268070.


CD11c B Cells Participate in the Pathogenesis of Graves' Disease by Secreting Thyroid Autoantibodies and Cytokines.

Cao Y, Zhao X, You R, Zhang Y, Qu C, Huang Y Front Immunol. 2022; 13:836347.

PMID: 35386700 PMC: 8977450. DOI: 10.3389/fimmu.2022.836347.


References
1.
Meier C, Beat M, Guglielmetti M, Christ-Crain M, Staub J, Kraenzlin M . Restoration of euthyroidism accelerates bone turnover in patients with subclinical hypothyroidism: a randomized controlled trial. Osteoporos Int. 2004; 15(3):209-16. DOI: 10.1007/s00198-003-1527-8. View

2.
Cooper D, Biondi B . Subclinical thyroid disease. Lancet. 2012; 379(9821):1142-54. DOI: 10.1016/S0140-6736(11)60276-6. View

3.
Morrison A, Fan T, Sen S, Weisenfluh L . Epidemiology of falls and osteoporotic fractures: a systematic review. Clinicoecon Outcomes Res. 2013; 5:9-18. PMC: 3536355. DOI: 10.2147/CEOR.S38721. View

4.
Egger M, Smith G . Meta-Analysis. Potentials and promise. BMJ. 1998; 315(7119):1371-4. PMC: 2127866. DOI: 10.1136/bmj.315.7119.1371. View

5.
Vestergaard P, Rejnmark L, Mosekilde L . Influence of hyper- and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk. Calcif Tissue Int. 2005; 77(3):139-44. DOI: 10.1007/s00223-005-0068-x. View